Study With Healthy Japanese and Non-Asian Participants With BMS-986231
Status:
Completed
Trial end date:
2017-05-26
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 1 study is to evaluate the safety, tolerability, PK, and
pharmacodynamics (PD) of BMS-986231 in healthy Japanese and Non-Asian participants. There is
no formal hypothesis to be statistically tested.